4/A

FORM 4/A SUBMISSION

Company: Aldeyra Therapeutics, Inc.
Filed: September 17, 2019
Period of Report: September 13, 2019
Accession Number: 0000899243-19-023735

View Document ↗ View on SEC.gov ↗